1
Diet and Plant Sterols in the Control of Cholesterolemia (DESCO)
Condition(s):HypercholesterolemiaLast Updated:March 3, 2022Recruiting
AREA[OverallStatus] Phytosterol as an Intervention, Open or Pending: 10 Clinical Trials
Include Studies Not Open or Pending
2
Plant Stanol Esters and Preventing Asthma Symptoms
Condition(s):Asthma, Allergic; Cardiovascular DiseasesLast Updated:September 3, 2020Recruiting
3
Plant Stanols and Liver Inflammation in Overweight and Obese Children
Condition(s):Non-Alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; NAFLD; NASH; NASH – Nonalcoholic Steatohepatitis; Childhood Obesity; Childhood Overweight; Pediatric ObesityLast Updated:March 5, 2021Not yet recruiting
4
Plant Sterol INtervention for Cancer Prevention (PINC)
Condition(s):Hypercholesterolemia; Breast Cancer; ObesityLast Updated:May 20, 2021Recruiting
5
Effects of Plant Sterols and Stanols on Liver Inflammation
Condition(s):NASH – Nonalcoholic SteatohepatitisLast Updated:September 8, 2021Recruiting
6
Survival Benefits of Statins in Breast Cancer Patients
Condition(s):Breast Cancer FemaleLast Updated:August 14, 2019Recruiting
7
The Combined Portfolio Diet and Exercise Study
Condition(s):Cardiovascular Diseases; Hypercholesterolemia; Type 2 Diabetes; Metabolic SyndromeLast Updated:October 10, 2019Recruiting
8
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
Condition(s):Multiple Sclerosis (MS)Last Updated:February 8, 2022Recruiting
9
Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
Condition(s):Spasticity With Multiple SclerosisLast Updated:July 1, 2022Recruiting
10
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Condition(s):Essential Fatty Acid Deficiency (EFAD)Last Updated:July 29, 2022Recruiting